Daprodustat US/EU sales projection: Consensus of $2B peak (Credit Suisse) - Dec 11, 2021 - A subscription to REFINITIV is required to access document 94480670 | Page no: 01 | REPORT TITLE: "GSK.L: GlaxoSmithKline plc - daprodustat P3 data underpins $2bn opportunity" | AUTHOR: Mr. Dominic Lunn, et al | DATE: 11/09/21
Anemia • Hematological Disorders
|
|
If you have access to Aftermarket Research from Refinitiv, please log in to your account using this link and enter report number or title to find the report. If you don’t have access but would like to purchase the report please contact OnDemand@refinitiv.com.
|